Category: Volcano Corp.
Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific reveals federal probe of BridgePoint buy, sales; Court defines 'breast implant' in Dow Corning's $2B product liability saga; Apex fights to get respiratory masks back in Germany; St. Jude and Volcano call a cease-fire
St. Jude Medical and Volcano agree to settle all litigation between them, putting to bed years of lawsuits over medical lasers and fractional flow reserve devices.
The Mass. Supreme Judicial Court denies St. Jude Medical's bid to overturn the portions of a lower court's ruling that went against it in its laser technology spat with Volcano Corp.
The highest court in Massachusetts largely denied
Jorge Quinoy, president of Volcano Corp.'s U.S. & APLAC commercial sales, is leaving the company effective today.
Volcano (NSDQ:VOLC) said last week that its president for U.S. & APLAC commercial sales, Jorge (George) Quinoy, is leaving the company effective today.
Here's a look at some of the top regulatory stories for medical device companies this week: Seven questions raised by Medtronic's $43B Covidien acquisition; Medtronic, Covidien merger: Good or bad for medtech innovation?; Medtronic, Covidien merger: Mass. Gov. Deval Patrick says he's had no contact with either company; Volcano closes $117M AtheroMed buy; Incubator group buys prostate treatment tech from Endo Health.
Volcano pays nearly $117 million in cash and puts another $15 million on the table in milestones for AtheroMed and its Phoenix atherectomy catheter system.
Volcano (NSDQ:VOLC) said yesterday that it closed the buyout of AtheroMed and its Phoenix atherectomy catheter system, paying out roughly $116.5 million in cash but netting about $1.7 million in cash on hand from AtheroMed.
Volcano Corp. continues to broaden its peripheral portfolio with the $115 million acquisition of FDA-cleared atherectomy systems maker AtheroMed.
Volcano (NSDQ:VOLC) hopes to change its reputation with the $115 million acquisition of privately held AtheroMed and its Phoenix atherectomy catheter system.